Abstract : The basic calponin gene, that encodes an actin-binding protein involved in the regulation of smooth muscle contractility, is specific to smooth muscle differentiation. Basic calponin is expressed by cultured mesangial cells, and localized along the actin filaments.
involved in the regulation of smooth muscle contractility, is specific to smooth muscle differentiation.
Basic calponin is expressed by cultured mesangial cells, and localized along the actin filaments.
Our previous studies suggested that down regulation of basic calponin correlates with mesangial cell proliferation, implying the involvement of basic calponin in suppressing mesangial cell proliferation.
In this study, we examined whether basic calponin is expressed in the glomerulus in anti-Thy 1.1 nephritis rats as an in vivo model for proliferative glomerulonephritis.
Basic calponin mRNA and protein were expressed in the proliferative phase of this model, and paralleled a -smooth muscle actin expression by mesangial cells.
Basic calponin may regulate excessive mesangial cell proliferation in this model. Elucidation of the molecular mechanisms regulating basic calponin expression in mesangial cells will contribute to an understanding of the molecular basis of the glomerular response to injury, which may be useful in the development of therapeutic interventions for human renal diseases.
Introduction
Glomerular mesangial cells are mesenchyme-derived multipotential cells which undergo phenotypic change as a result of a -smooth muscle actin ( a SMA) expression during glomerular inflammation" 2). Phenotypic change of mesangial cells is tightly associated with activation, proliferation, and early response to mediators, and also to the synthesis and release of extracellular matrix protein, chemical mediators and vasoactive substances. Therefore an understanding of the regulation of mesangial cell phenotypic change may provide useful insight into future therapeutic strategies for progressive glomerulonephritis. It may be possible to regulate the phenotypic change of mesangial cells by controlling the expression of smooth muscle-associated genes. There are several contractile proteins associated with phenotypic modulation of vascular smooth muscle cells. Calponin is one such protein and is the focus of this study. Calponin was originally isolated as an actin-binding protein involved in the regulation of smooth muscle contraction2-4) . Three distinct mammalian calponin genes have been identified and include basic calponin (calponin hi), neutral calponin (calponin h2), and acidic calponin5-7). Expression of the basic calponin gene specifically marks smooth muscle cell differentiation3,8-11) while the neutral and acidic calponin genes are expressed in both smooth muscle and non-smooth muscle cells6,7) . Basic calponin is capable of inhibiting actomyosin ATPase activity 12,13), induces actin polymerization at low ionic strength and inhibits depolymerization of actin filaments14). Overexpression of basic calponin in cultured smooth muscle cells, fibroblasts and tumor cells suppresses their proliferation15,16) Taken together, these observations suggest that, in addition to the regulation of smooth muscle contractility, basic calponin may control cytoskeleton formation and may therefore influence cytokinesis, proliferation and differentiation of cells. In this study, we examined the in vivo expression of basic calponin in a rat model of mesangial proliferative glomerulonephritis induced by the anti-thvmocvte monoclonal antibody, anti-Thy 1.1. Thirty Wistar male rats weighing 180 to 200 g (Nippon Ikagaku Doubutsu, Tokyo, Japan) were fed with standard rat chow (Oriental Yeast Co. Ltd., Tokyo, Japan). The disease was induced in twenty-five rats by a single intravenous injection of anti-Thy 1.1 monoclonal antibody using 2.5 ml/kg of a 10% solution (Cedarlane Laboratories Limited, Hornby, Ontario, Canada) as previously described17). At day 2, 4, 7, 12 and 20 following induction of the disease a total of five rats for each time point were sacrificed. The kidneys were removed for histological study, and total RNA was extracted for RT-PCR analysis. As a control five normal rats were sacrificed at day 0.
Renal morphology and immunohistochemical staining in anti-Thy 1.1 nephritis Tissue for light microscopy and immunoperoxidase staining was fixed in methyl Carnoy's solution 18) and embedded in paraffin. Four-micrometer sections were stained using the indirect immunoperoxidase method. Primary antibodies included the following: 19A2 (Coulter Immunology, Hialeah, FL, USA), a murine monoclonal antibody against human PCNA, which is an auxiliary protein to DNA polymerase delta that is expressed in late G1, peaking during S phase, and extending to the M phase of the cell cycle; an IgG fraction of the murine monoclonal antibody to a SMA (DAKO, Glostrup, Denmark), which has been shown to stain activated mesangial cells in vivo19) ; and a polyclonal antibody to synthetic carboxyl-terminal peptides (Leu-281-A1a-297) of human basic calponin generated in rabbits20) . Quantification of proliferating PCNA + cells was performed by examining biopsies, in a blinded manner, containing more than 20 discrete capillary segments each (range, 20 to 38; mean 26.8 ± 6.6) and recording the number of positive cells per glomerular cross section21). Staining for a SMA and basic calponin was evaluated by grading each glomerulus semiquantitatively as previously described22' 23), Enumeration is as follows: 0, diffuse, very weak, or absent mesangial matrix staining and no localized increase of staining; 1+, diffuse weak mesangial matrix staining with 1 to 25% of the glomerular tuft showing focally increased staining; 2+, 25 to 50% of the glomerular tuft demonstrating Linear production of PCR products for calponin and GAPDH was obtained between 25 and 30 cycles. After 1 % agarose gel electrophoresis in the presence of 0.5 /ag/ml ethidium bromide, PCR products were revealed by UV irradiation and the image was captured by NIH image analysis (version 1.61). Semiquantitative levels of basic calponin mRNA were normalized to equivalent levels of GAPDH mRNA per sample.
Negative controls, including a sample with PCR reagents in the absence of RT reaction mixture, showed no specific signals. F) and PCNA (G-J) in normal and anti-Thy 1.1 nephritis rats. Positive staining for basic calponin was observed in smooth muscle cells of arteries in renal tissue from both normal and diseased rats. However, there was almost no positive staining for basic calponin in the glomerulus in rats of day 0 (a) and day 2 (b), respectively. The staining intensity was greatest for the basic calponin protein in the mesangium after day 4 (c). Basic calponin proteins levels then decreased. a SMA expression was observed only in the arterial wall at day 0 (A), but after day 2 (B) expression had increased. A marked increase in the number of PCNA + cells was observed from day 2 to day 7. Immunoperoxidase, X 400, a-f : basic calponin, A-F : a SMA, G-J : PCNA ; a, A and G : day 0 ; b, B and H : day 2 ; c, C and I : day 4 ; d, D and J : day 7 ; e and E : day 12 ; f and F : day 20 (after disease induction, respectively). Expression of basic calponin mRNA in mesangial proliferative nephritis Basic calponin mRNA expression in the glomerulus was analysed by RT-PCR. There was no basic calponin mRNA expression at day 2 or day 0. Increased gene expression was greatest at day 4 and decreased gradually thereafter in parallel with changes in the protein Fig. 3 . Basic calponin mRNA expression in the glomerulus analyzed by RT-PCR. There was only faint basic calponin mRNA expression at day 2 and day 0. Increased gene expression was at a maximum level at day 4 and decreased gradually thereafter. For each sample semiquantitative levels of basic calponin mRNA were normalized using equivalent levels of GAPDH mRNA. Expression ratios were 11.80 (day 4) : 6.59 (day 7) : 1.82 (day 12).
level as shown by immunostaining. The ratio of basic calponin mRNA compared to normal rats was 11.80 (day 4), 6.59 (day 7) and 1.82 (day 12), (Fig. 3) . There was no gene expression in negative control samples.
Discussion
Phenotypic modulation and dedifferentiation of mesangial cells is a characteristic feature of glomerular diseases28'. Expression of a SMA is a marker for activation and phenotypic modulation of mesangial cells1). Previous studies demonstrate that a core sequence of the a SMA promoter, containing two highly conserved CArG box motifs, is essential for serum-stimulated a SMA expression in rat mesangial cells29). We have already reported that basic calponin, a smooth muscle-differentiation specific gene, is expressed at a high level, and localized along actin filaments in cultured mesangial cells30). Also, we have shown that treatment with anti-glomerular basement membrane antibody induces more severe nephritis in basic calponin knockout mice than in wild type mice based on urinary protein excretion, glomerular cellularity, expression of PCNA, crescentic formation and interstitial cellularity30) We therefore speculate that down-regulation of basic calponin correlates with promotion of mesangial cell proliferation, and that basic calponin suppresses mesangial cell proliferation. This is consistent with the finding that overexpression of basic calponin in smooth muscle cells, fibroblasts and tumor cells inhibits their proliferation15•'61. As a next step, investigation of basic calponin expression in the glomerulus in glomerulonephritis in vivo is necessary. Using the anti-Thy 1.1 rat model for nephritis we showed that basic calponin mRNA and protein are expressed in the proliferative phase of glomerulonephritis and parallel the expression of a SMA by mesangial cells. Cultured human mesangial cells that overexpress basic calponin show reduced PDGF-BB induced proliferation, and excessive mesangial cell proliferation in anti-Thy 1.1 nephritis is suppressed in basic calponin transgenic rats31) . Therefore, expression of basic calponin in mesangial cells may function as an intrinsic regulator in proliferative glomerular injuries. Apoptosis is important in the progression of anti-Thy 1.1 nephritis, however the relationship between calponin expression and mesangial cell apotosis is unknown. Elucidation of the molecular mechanism regulating basic calponin expression in mesangial cells will contribute to an understanding of the molecular basis of the glomerular response to injury, and may be useful in the development of therapeutic interventions for human renal diseases. 
